Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rheumatoid arthritis vaccine - Immune Response BioPharma

Drug Profile

Rheumatoid arthritis vaccine - Immune Response BioPharma

Alternative Names: AI 201; AI 204; AI 205; IR 201; IR 501; IR 703; RAVAX; Zyvac-RA

Latest Information Update: 10 Jul 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Immune Response Corporation
  • Developer Immune Response BioPharma
  • Class Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Rheumatoid arthritis

Most Recent Events

  • 10 Jul 2019 RAVAX™ vaccine is still in phase III trials for Rheumatoid arthritis in USA
  • 18 May 2015 The vaccine is still in phase-III development for Rheumatoid arthritis in USA
  • 04 Feb 2014 Ravax™ is still in phase III development for Rheumatoid arthritis in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top